abstract |
A method of diagnosis or of quantitation of cancer comprising obtaining a patient biofluid sample, conducting an immunoassay to measure fragments of Nidogen-1 having an N- or C-terminal neo-epitope formed by cleavage of Nidogen-1 by Cathepsin-S, said fragments being naturally present in said sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of cancer. |